Search filters

Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 4
  • 7
  • 2
  • 1
  • 2
  • 4

Found 7 Menopause trials

A listing of Menopause medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
A5424 HoT
40 years - 60 years
All genders
Are you experiencing hot flashes or night sweats?We are testing a menopausal hormone therapy for hot flashes, night sweats, and other symptoms.
99 years or below
All genders
MZE829-201 is a Phase 2, open-label study of MZE829 in adults aged 18 to 65 years with proteinuric chronic kidney disease (CKD) and the APOL1 high risk genotype, or APOL1 Kidney Disease (AKD). It aims to evaluate the safety and tolerability of MZE829 in adults with proteinuric AKD, to evaluate …
22 years - 75 years
All genders
Phase 1
This dual-site, double-blinded, randomized, sham-controlled, crossover study is to assess the safety, feasibility, and preliminary efficacy of SEEG-guided multi-lead DBS in 10 participants suffering from severe symptoms of chronic, treatment-refractory OCD. Stage 1: Invasive SEEG Monitoring and Recovery Goal: To perform stimulation mapping studies and SEEG recordings, that aid in …
99 years or below
All genders
Primary Objective: To compare the efficacy of 2 doses of BHV-7000 to placebo as an adjunctive therapy for refractory focal onset epilepsy as measured by the change from baseline in 28-day average seizure frequency. Secondary Objcetives: -To compare the efficacy of 2 doses of BHV-7000 to placebo as adjunctive therapy …
35 years - 50 years
Female
Interventional
This study investigates the effectiveness of two surgical procedures in reducing the risk of ovarian cancer in individuals with BRCA1 mutations. The purpose of this study is to compare bilateral salpingectomy, which involves removing the fallopian tubes, with bilateral salpingo-oophorectomy, which involves removing both the fallopian tubes and ovaries. These …
18 years or above
Female
Phase 2
This study aims to learn more about the use of Mirvetuximab soravtansine and Olaparib as a maintenance therapy after completion of prior therapy for recurrent platinum sensitive ovarian, peritoneal and fallopian tube cancer. Mirvetuximab soravtansine is an effective antibody drug conjugate that targets folate receptor alpha. Olaparib is one of …
18 years or above
Male
Phase 3
Interventional
This study investigates the effectiveness of adding enhanced therapy to standard treatment for prostate cancer patients experiencing biochemical recurrence. The study aims to compare standard prostate radiation therapy combined with short-term androgen deprivation to an enhanced therapy regimen that includes additional medications. Another aspect of the study examines the use …